Table 4 Crude and adjusted association between background characteristics of mothers, ANC service utilization and uptake of ≥3 doses of SP
Characteristics | IPTp-SP uptake | COR | p-value | AOR (95%CI) | p-value | |
|---|---|---|---|---|---|---|
< 3 doses n = 22(%) | ≥3 doses n = 190(%) | (95%CI) | ||||
Educational level | ||||||
Formal | 14 (7.4) | 175 (92.6) | ref | |||
No formal | 8 (34.8) | 15 (65.2) | 6.67 (2.41–18.41) | 0.040 | 1.31 (0.20–8.39) | 0.776 |
Gestational age at first ANC | ||||||
First trimester | 8 (8.8) | 83 (39.6) | ref | |||
Second trimester | 9 (8.3) | 100 (91.7) | 1.91 (1.17–3.14) | 0.009 | 0.94 (0.31–2.85) | 0.918 |
Third trimester | 5 (41.7) | 7 (58.3) | 0.95 (0.61–1.50) | 0.840 | ||
Gestational age at first dose of SP | ||||||
Second trimester | 16 (8.3) | 52 (26.8) | ref | |||
Third trimester | 6 (33.3) | 12 (66.7) | 5.56 (1.84–16.80) | 0.002 | 5.37 (0.51–56.82) | 0.162 |
Side effects | ||||||
No side effects | 15 (15.5) | 82 (84.5) | ref | |||
Experienced effects | 93 (80.9) | 108 (93.9) | 0.35 (0.14–0.91) | 0.031 | 1.02 (0.21–5.00) | 0.981 |
Interval between SP doses | ||||||
Monthly | 16 (8.5) | 172 (91.5) | ref | |||
Does not know | 6 (25.0) | 18 (75.0) | 3.58 (1.25–10.31) | 0.018 | 0.99 (0.14–6.89) | 0.993 |
Number of ANC visits | ||||||
< 4 | 16 (66.7) | 8 (33.3) | 60.67 (1.25–10.31) | < 0.001 | 53.77 (7.23–399.62) | < 0.001 |
≥ 4 | 6 (3.2) | 182 (96.8) | ref | |||